BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

511 related articles for article (PubMed ID: 17076304)

  • 21. Maintenance electroconvulsive therapy combined with long-acting risperidone in the treatment of resistant bipolar affective disorder.
    Sengul C; Kalkanci O; Simsek D; Herken H
    J ECT; 2009 Dec; 25(4):282-3. PubMed ID: 19440160
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ECT and clozapine in schizophrenia.
    Fink M
    J ECT; 1998 Dec; 14(4):223-6. PubMed ID: 9871841
    [No Abstract]   [Full Text] [Related]  

  • 23. Optimizing clozapine treatment.
    Nielsen J; Damkier P; Lublin H; Taylor D
    Acta Psychiatr Scand; 2011 Jun; 123(6):411-22. PubMed ID: 21534935
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment pathway and patterns of clozapine prescribing for schizophrenia in New Zealand.
    Wheeler AJ
    Ann Pharmacother; 2008 Jun; 42(6):852-60. PubMed ID: 18477732
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Using ECT in schizophrenia: a review from a clinical perspective.
    Zervas IM; Theleritis C; Soldatos CR
    World J Biol Psychiatry; 2012 Feb; 13(2):96-105. PubMed ID: 21486108
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clozapine-induced myocarditis after long-term treatment: case presentation and clinical perspectives.
    Lang UE; Willbring M; von Golitschek R; Schmeisser A; Matschke K; Malte Tugtekin S
    J Psychopharmacol; 2008 Jul; 22(5):576-80. PubMed ID: 18308817
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The use of clozapine in adults with intellectual disability.
    Thalayasingam S; Alexander RT; Singh I
    J Intellect Disabil Res; 2004 Sep; 48(Pt 6):572-9. PubMed ID: 15312058
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A double-blind study of combination of clozapine with risperidone in patients with schizophrenia: effects on cognition.
    Akdede BB; Anil Yağcioğlu AE; Alptekin K; Turgut TI; Tümüklü M; Yazici MK; Jayathilake K; Tunca Z; Göğüş A; Meltzer HY
    J Clin Psychiatry; 2006 Dec; 67(12):1912-9. PubMed ID: 17194269
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Maintenance electroconvulsive therapy: an alternative treatment for refractory schizophrenia and schizoaffective disorders.
    Lévy-Rueff M; Gourevitch R; Lôo H; Olié JP; Amado I
    Psychiatry Res; 2010 Feb; 175(3):280-3. PubMed ID: 20034675
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Electroconvulsive therapy in treatment-resistant schizophrenia: prediction of response and the nature of symptomatic improvement.
    Chanpattana W; Sackeim HA
    J ECT; 2010 Dec; 26(4):289-98. PubMed ID: 20375701
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Augmentation of clozapine with ECT: a retrospective case analysis.
    Lally J; Breese E; Osman M; Hua Sim C; Shetty H; Krivoy A; MacCabe JH
    Acta Neuropsychiatr; 2021 Feb; 33(1):31-36. PubMed ID: 32967745
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Is electroconvulsive therapy effective as augmentation in clozapine-resistant schizophrenia?
    Kittsteiner Manubens L; Lobos Urbina D; Aceituno D
    Medwave; 2016 Oct; 16(Suppl5):e6577. PubMed ID: 27813505
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Successful use of maintenance electroconvulsive therapy in the treatment of clozapine-associated obsessive-compulsive symptoms in schizophrenia: a case report.
    Rao NP; Antony A; Raveendranathan D; Venkatasubramanian G; Behere RV; Varambally SS; Gangadhar BN
    J ECT; 2011 Mar; 27(1):e37-8. PubMed ID: 20938347
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term combination treatment with clozapine and filgrastim in patients with clozapine-induced agranulocytosis.
    Hägg S; Rosenius S; Spigset O
    Int Clin Psychopharmacol; 2003 May; 18(3):173-4. PubMed ID: 12702898
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Advantages and disadvantages of combination treatment with antipsychotics ECNP Consensus Meeting, March 2008, Nice.
    Goodwin G; Fleischhacker W; Arango C; Baumann P; Davidson M; de Hert M; Falkai P; Kapur S; Leucht S; Licht R; Naber D; O'Keane V; Papakostas G; Vieta E; Zohar J
    Eur Neuropsychopharmacol; 2009 Jul; 19(7):520-32. PubMed ID: 19411165
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatments for late-life bipolar disorder.
    Aziz R; Lorberg B; Tampi RR
    Am J Geriatr Pharmacother; 2006 Dec; 4(4):347-64. PubMed ID: 17296540
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Electroconvulsive monotherapy in the treatment of acute confusion psychosis. A case report.
    Neuhaus AH; Katchanov J; Opgen-Rhein C; Neu P; Jockers-Scherübl MC
    Pharmacopsychiatry; 2005 Nov; 38(6):330-2. PubMed ID: 16342009
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Electroconvulsive therapy for the treatment of clozapine nonresponders suffering from schizophrenia--an open label study.
    Kho KH; Blansjaar BA; de Vries S; Babuskova D; Zwinderman AH; Linszen DH
    Eur Arch Psychiatry Clin Neurosci; 2004 Dec; 254(6):372-9. PubMed ID: 15538604
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Seizures associated with clozapine treatment in a state hospital.
    Wilson WH; Claussen AM
    J Clin Psychiatry; 1994 May; 55(5):184-8. PubMed ID: 8071267
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of lipid-lowering medications in patients treated with clozapine: a naturalistic study.
    Landry P; Dimitri E; Tessier S; Légaré N
    J Clin Psychopharmacol; 2008 Jun; 28(3):348-9. PubMed ID: 18480696
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.